Skip to main content
. Author manuscript; available in PMC: 2022 Feb 3.
Published in final edited form as: J Cancer Immunol (Wilmington). 2021;3(4):183–187.

Figure 1:

Figure 1:

A schematic representation of a fully human (A), a murine (B), a chimeric (C), a humanized monoclonal antibody (mAb) (D), and a humanized single-chain variable fragment (scFv) (E).